ALID (ALID) Stock Price & Analysis
ALID (ALID) rose 0.00% to USD 0 as of June 10, 2026 at 07:10 UTC, according to Nexqual real-time market data.
ALID last closed at USD 0; the session ranged USD 0.01–0.01 on volume of 285 shares. Market capitalization is $57,747, with a 52-week range of USD 0–0.01 (PNK). Source: Nexqual, June 10, 2026 at 07:10 UTC.
Key Statistics (as of June 10, 2026 at 07:10 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0.01 |
| Day Range | USD 0.01 – 0.01 |
| 52-Week Range | USD 0 – 0.01 |
| Volume | 285 shares |
| Market Cap | $57,747 |
| Exchange | PNK |
Technical Analysis (ALID)
Nexqual's technical model rates ALID "BUY" based on 4 bullish and 1 bearish signals across 124 daily candles, as of June 10, 2026 at 07:10 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 100 (overbought) |
| vs SMA50 | Below (USD 0) |
| MACD | 0 (negative) |
Analyst Ratings (ALID)
Wall Street analysts rate ALID "None", per Nexqual as of June 10, 2026 at 07:10 UTC.
| Consensus Rating | None |
|---|
Earnings (ALID)
Source: Nexqual, June 10, 2026 at 07:10 UTC.
Financials & Fundamentals (ALID)
| Total Revenue | $104,810 |
|---|---|
| Revenue Growth (YoY) | +45.30% |
| Gross Margin | +0.00% |
| Operating Margin | -1860.22% |
| Profit Margin | +0.00% |
| Current Ratio | 0.07 |
| Total Cash | $195,350 |
| Total Debt | $6.71M |
| Free Cash Flow | $-2.10M |
Source: Nexqual, June 10, 2026 at 07:10 UTC.
Financial Health Score (ALID)
Nexqual rates ALID's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 07:10 UTC.
| Growth | Strong — Revenue +45% YoY (latest Q) |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Mixed — $195K cash vs $7M debt |
| Cash Flow | Weak — FCF negative: -$2M, burning cash |
| Efficiency | Mixed — No data |
Ownership (ALID)
| Insider Ownership | +47.16% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 115.50M |
| Float | 84.43M |
Source: Nexqual, June 10, 2026 at 07:10 UTC.
Leadership (ALID)
ALID is led by Michael Moses, Chief Executive Officer, per Nexqual as of June 10, 2026 at 07:10 UTC.
| Chief Executive Officer | Michael Moses |
|---|---|
| COO, Interim CFO & Director | Paul Bullock |
| Chief Scientific Director | Radka Milanova |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| WSNAF | WESANA HEALTH HLDGS INC. | USD 0.02 | ▲ 0% |
| MYCOF | MYDECINE INNOVATIONS GROUP INC | USD 2 | ▲ 0% |
| AVCNF | Avicanna Inc. | USD 0.08 | ▼ 3.61% |
| DELCF | DELIC HOLDINGS CORP | USD 0 | ▲ 0% |
| FDCT | FDCTech, Inc. | USD 0.06 | ▼ 1.64% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 07:10 UTC. This page is informational and not investment advice.